Chen et al., 2021 - Google Patents

Early Gut Microbiota Changes in Preterm Infants with Bronchopulmonary Dysplasia: A Pilot Case–Control Study

Chen et al., 2021

Document ID
11463422017679829047
Author
Chen S
Lin C
Jan M
Publication year
Publication venue
American journal of perinatology

External Links

Snippet

Objective Bronchopulmonary dysplasia (BPD) is a complex chronic lung disease that primarily affects premature or critically ill infants. This pilot study investigated early changes in gut microbiota composition in BPD patients and explored the potential risk factors …
Continue reading at www.thieme-connect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/345—Medical expert systems, neural networks or other automated diagnosis

Similar Documents

Publication Publication Date Title
Chen et al. Early Gut Microbiota Changes in Preterm Infants with Bronchopulmonary Dysplasia: A Pilot Case–Control Study
Steinbeis et al. Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months
Gaibani et al. The gut microbiota of critically ill patients with COVID-19
Bunyavanich et al. Early-life gut microbiome composition and milk allergy resolution
Nguyen et al. Impact of probiotic B. infantis EVC001 feeding in premature infants on the gut microbiome, nosocomially acquired antibiotic resistance, and enteric inflammation
Stewart et al. Development of the preterm gut microbiome in twins at risk of necrotising enterocolitis and sepsis
Chen et al. Alterations in the gut microbiotas of children with food sensitization in early life
Rigsbee et al. Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome
Yuan et al. Feeding intolerance alters the gut microbiota of preterm infants
Salomon et al. Dysbiosis and intestinal barrier dysfunction in pediatric congenital heart disease is exacerbated following cardiopulmonary bypass
de Cuevillas et al. Fecal microbiota relationships with childhood obesity: a scoping comprehensive review
Lai et al. Effect of different delivery modes on intestinal microbiota and immune function of neonates
Ceylani et al. The effect of young blood plasma administration on gut microbiota in middle-aged rats
Ge et al. Application of machine learning tools: Potential and useful approach for the prediction of type 2 diabetes mellitus based on the gut microbiome profile
Neelis et al. Gut microbiota and its diet‐related activity in children with intestinal failure receiving long‐term parenteral nutrition
Freire et al. Frequency and factors associated with hospital readmission after COVID-19 hospitalization: the importance of post-COVID diarrhea
Bajorek et al. B. infantis EVC001 is well-tolerated and improves human milk oligosaccharide utilization in preterm infants in the neonatal intensive care unit
Guo et al. Fecal Coprococcus, hidden behind abdominal symptoms in patients with small intestinal bacterial overgrowth
Brewer et al. Determinants of the lung microbiome in intubated premature infants at risk for bronchopulmonary dysplasia
Zhou et al. The gut-lung axis in critical illness: microbiome composition as a predictor of mortality at day 28 in mechanically ventilated patients
Jiang et al. Dysbiosis of the gut microbiota in glioblastoma patients and potential biomarkers for risk assessment
KR20230097075A (en) How to Treat Autism Spectrum Disorder
WO2019226751A1 (en) Composition and methods for predicting necrotizing enterocolitis in preterm infants
Li et al. Gut microbiota markers for antipsychotics induced metabolic disturbance in drug naïve patients with first episode schizophrenia–a 24 weeks follow-up study
Graf et al. Maternal Prenatal Stress and the Offspring Gut Microbiome: A Cross‐Species Systematic Review